WealthTrust-Arizona’s Ligand Pharmaceuticals LGND Stock Holding History

WealthTrust-Arizona’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$41K	Hold	481	–	–	0.02%	176
2018 Q3	$82K	Hold	481	–	–	0.04%	115
2018 Q2	$62K	Hold	481	–	–	0.03%	128
2018 Q1	$50K	Buy	481 +321	+201%	+$31.7K	0.03%	159
2017 Q4	$14K	Hold	160	–	–	0.01%	351
2017 Q3	$14K	Sell	160 -481	-75%	-$38.1K	0.01%	340
2017 Q2	$49K	Sell	641 -161	-20%	-$11.3K	0.03%	157
2017 Q1	$53K	Hold	802	–	–	0.03%	150
2016 Q4	$51K	Hold	802	–	–	0.03%	147
2016 Q3	$51K	Sell	802 -320	-29%	-$23.5K	0.03%	138
2016 Q2	$83K	Hold	1,122	–	–	0.05%	104
2016 Q1	$75K	Buy	1,122 +240	+27%	+$14.6K	0.05%	109
2015 Q4	$60K	Hold	882	–	–	0.04%	135
2015 Q3	$47K	Hold	882	–	–	0.03%	151
2015 Q2	$55K	Hold	882	–	–	0.03%	148
2015 Q1	$42K	Hold	882	–	–	0.03%	184
2014 Q4	$29K	Hold	882	–	–	0.02%	207
2014 Q3	$26K	Hold	882	–	–	0.03%	235
2014 Q2	$34K	Hold	882	–	–	0.04%	214
2014 Q1	$37K	Buy	882 +401	+83%	+$16.7K	0.04%	197
2013 Q4	$16K	Buy	481 +160	+50%	+$5.21K	0.02%	311
2013 Q3	$9K	Buy	+321	New	+$9.03K	0.01%	392

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

WealthTrust-Arizona's LGND Position: Q4 2018 in Review

WealthTrust-Arizona held its Ligand Pharmaceuticals (LGND) position steady in Q4 2018 at 481 shares worth $41K. The position accounts for 0.02% of the portfolio, ranked #176.

WealthTrust-Arizona first reported a position in LGND in Q3 2013 and has held it in 22 quarters since. The position peaked at $83K in Q2 2016. 362 funds tracked by Wall St. Rank hold LGND as of Q4 2018.

WealthTrust-Arizona held 481 shares of Ligand Pharmaceuticals worth $41K as of Q4 2018.
WealthTrust-Arizona left its Ligand Pharmaceuticals share count unchanged in Q4 2018.
Ligand Pharmaceuticals made up 0.02% of WealthTrust-Arizona's portfolio in Q4 2018, its #176 holding.
WealthTrust-Arizona first reported a position in Ligand Pharmaceuticals in Q3 2013 and has held it in 22 quarters since.
WealthTrust-Arizona's Ligand Pharmaceuticals position peaked at $83K in Q2 2016.
362 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2018.

Based on WealthTrust-Arizona's 13F filing for Q4 2018, filed 7 Feb 2019.